AIA Filings on 13 January 2015
Boston Heart Diagnostics Corporation filed an Inter Partes Review (IPR) petition on Tuesday January 13, 2015 against HEALTH DIAGNOSTIC LABORATORY, INC. for patent US8119358 GP Strategies Corporation filed an…
Boston Heart Diagnostics Corporation filed an Inter Partes Review (IPR) petition on Tuesday January 13, 2015 against HEALTH DIAGNOSTIC LABORATORY, INC. for patent US8119358 GP Strategies Corporation filed an…
Dicerna Pharma (DRNA) Receives U.S. Patent Covering DsiRNA-EX Dicerna Pharma announced that the United States Patent and Trademark Office (USPTO) issued to Dicerna Patent No. 8,927,705, “Single Stranded Extended Dicer…
RPX Corporation filed an Inter Partes Review (IPR) petition on Monday January 12, 2015 against MULTIPLAYER NETWORK INNOVATIONS, LLC for patent US5618045 Alcohol Monitoring Systems, Inc. filed an Inter…
USPTO Reduces Fees for Trademark Applications and Renewals in 2015 Effective January 17, 2015, the USPTO has announced a number of fee reductions for 2015, including a $50 reduction in…
Samsung Electronics Co. Ltd. filed an Inter Partes Review (IPR) petition on Friday January 09, 2015 against REMBRANDT WIRELESS TECHNOLOGIES, LP for patent US8457228 CQG, INC. filed Two Covered…
Novartis files infringement claim against Ranbaxy over Gleevec patent Novartis Pharmaceuticals sued Ranbaxy, Inc. and Ranbaxy Laboratories on Dec. 29 over allegations of patent infringement. The suit followed the defendants'…
AMNEAL PHARMACEUTICALS LLC. and PAR PHARMACEUTICAL, INC. filed Four Inter Partes Review (IPR) petitions on Thursday January 08, 2015 against JAZZ PHARMACEUTICALS, INC. for patents US8589182, US7765106, US7765107, and US7668730…
Michael R. Braden filed an Inter Partes Review (IPR) petition on Wednesday January 07, 2015 against Mark N. Chaffin for patent US6932912 Samsung Electronics Co., Ltd. filed Two Inter…
Scifluor Life Sciences Awarded US Patent for KCNQ2/3 Activator Designed for Treatment of Epilepsy and Related Neurological Disorders SciFluor Life Sciences, LLC, an emerging clinical stage biopharmaceutical company that creates…